AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 63 filers reported holding AMRYT PHARMA PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,546 | +449.1% | 380,359 | +174.8% | 0.00% | +200.0% |
| Q4 2022 | $1,010 | -99.9% | 138,391 | -46.6% | 0.00% | 0.0% |
| Q3 2022 | $1,793,000 | +7.9% | 259,126 | +9.1% | 0.00% | 0.0% |
| Q2 2022 | $1,661,000 | -22.9% | 237,608 | -8.8% | 0.00% | 0.0% |
| Q1 2022 | $2,153,000 | -25.1% | 260,661 | -2.1% | 0.00% | 0.0% |
| Q4 2021 | $2,876,000 | -26.0% | 266,256 | -17.2% | 0.00% | -50.0% |
| Q3 2021 | $3,888,000 | – | 321,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,292,000 | 22.96% |
| Stonepine Capital Management, LLC | 6,227,733 | $43,096,000 | 19.37% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,468,000 | 7.03% |
| Aquilo Capital Management, LLC | 1,998,993 | $13,833,000 | 4.99% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,112,000 | 1.85% |
| Global Frontier Investments LLC | 505,000 | $3,495,000 | 1.77% |
| Rubric Capital Management LP | 3,600,000 | $24,912,000 | 1.26% |
| Telemetry Investments, L.L.C. | 123,000 | $851,000 | 1.09% |
| Nantahala Capital Management | 1,437,458 | $9,947,000 | 0.64% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $43,828,000 | 0.62% |